Wall Street Strategists Sound Alarm on Worsening Profit Outlook

(Bloomberg) — The outlook for earnings is weakening and could remain subdued, according to strategists from Morgan Stanley to JPMorgan Chase & Co. As the reporting season kicks off, Morgan Stanley’s Michael Wilson said earnings revisions breadth — referring to the number of stocks seeing upgrades versus downgrades — for the S&P 500 has fallen […]

Wells Fargo Kicks Off Top US Banks’ Post-Earnings Bond Issuance

(Bloomberg) — Wells Fargo & Co. is the first of the six biggest Wall Street banks to tap the US investment-grade market after reporting third-quarter earnings. The lender is selling bonds in as many as two parts, according to a person with knowledge of the matter. The longest portion of the self-led offering, a 11-year […]

London Banker Bonuses Drop as Prolonged Deal Slump Takes Toll

(Bloomberg) — Junior investment bankers in London received significantly smaller bonuses in 2023 as a prolonged slump in mergers and acquisitions and economic uncertainty dulled pay rewards across the board. Bonuses for first-year analysts fell to an average of 43.2% of base salary in summer 2023, down from 55.3% last year, according to a report […]

Neuberger Berman Pushes Lions Gate to End Dual-Class Structure

(Bloomberg) — Neuberger Berman is submitting a shareholder proposal to Lions Gate Entertainment Corp., advocating for an end to the dual-class voting structure at the company ahead of a spinoff of its studio business. The investment manager owns 0.02% of the company’s class A shares and 4.4% of the non-voting class B shares, according to […]

Novo to Buy Experimental Heart Drug for Up to $1.3 Billion

(Bloomberg) — Novo Nordisk A/S agreed to buy an experimental blood-pressure medicine from KBP Biosciences for as much as $1.3 billion, extending a string of recent deals to bolster its drug pipeline.  The treatment, called ocedurenone, is currently in late-stage testing for people with uncontrolled hypertension and advanced, chronic kidney disease, the Danish drugmaker said […]

Tusk Sets Out to Rebuild Polish Institutions After Populist Rule

(Bloomberg) — Donald Tusk is set to return as Poland’s prime minister, putting him in position to unlock billions in European Union funding and begin restoring independent institutions after eight years of nationalist rule.  His top priorities include normalizing relations with the rest of the EU after the rancor of the Law & Justice government […]

SocGen’s Krupa Seeks to Keep His Sale Plan Secret. Here’s a List

(Bloomberg) — When Societe Generale SA Chief Executive Officer Slawomir Krupa unveiled his new strategy last month, he refused to provide any details about which parts of the lender he’d like to sell. While acknowledging that the lack of clarity was “an element of frustration” for investors, he said the information was “highly sensitive.” His […]

Citigroup Hires Credit Suisse’s Scott Bardo for Europe Medtech

(Bloomberg) — Citigroup Inc. has hired Credit Suisse investment banker Scott Bardo as it seeks to beef up its ranks of health-care dealmakers.  Bardo is set to join Citigroup as a managing director and head of medical technology, life sciences tools and diagnostics for Europe, the Middle East and Africa, according to an internal memo […]

Viktor Orban Loses Key Polish Ally Inside the EU’s Awkward Squad

(Bloomberg) — It’s not just Poland’s nationalist leadership that’s been upset by a surprise election victory for the pro-European Union opposition. Hungarian Prime Minister Viktor Orban’s self-described illiberal democracy is now suddenly more isolated than ever in the bloc as the fate of billion of euros in aid from Brussels hangs in the balance.   […]